Cadrenal Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Ponte Vedra, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Cadrenal Therapeutics, Inc. has filed 269 SEC EDGAR filings since 15 Jul 2022

SEC filing history

Showing 126-150 of 269 matching filings.

Per page
25
Current page
6
S-8 File 333-284672

REGISTRATION STATEMENT

Filing date
03 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-94027

SCHEDULE 13D filing

Filing date
29 Jan 2025
Reporting date
Not listed
Next action
Verify source filing
4

4 filing

Filing date
24 Jan 2025
Reporting date
23 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Jan 2025
Reporting date
23 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Jan 2025
Reporting date
23 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Jan 2025
Reporting date
23 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Jan 2025
Reporting date
23 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Jan 2025
Reporting date
23 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Jan 2025
Reporting date
23 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-94027

SCHEDULE 13G/A filing

Filing date
15 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-284024

REGISTRATION STATEMENT

Filing date
23 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-277835

PROSPECTUS SUPPLEMENT

Filing date
20 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-283226

PROSPECTUS

Filing date
25 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-283226

EFFECT filing

Filing date
22 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
21 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-283226

UPLOAD filing

Filing date
20 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-283226

REGISTRATION STATEMENT

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-94027

SC 13G/A filing

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-529374

D filing

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-41596

QUARTERLY REPORT

Filing date
07 Nov 2024
Reporting date
30 Sep 2024
Next action
Verify source filing
8-K File 001-41596

CURRENT REPORT

Filing date
07 Nov 2024
Reporting date
07 Nov 2024
Next action
Verify source filing
8-K File 001-41596

CURRENT REPORT

Filing date
04 Nov 2024
Reporting date
01 Nov 2024
Next action
Verify source filing
424B5 File 333-273384

PROSPECTUS SUPPLEMENT

Filing date
04 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41596

CURRENT REPORT

Filing date
24 Oct 2024
Reporting date
24 Oct 2024
Next action
Verify source filing
SC 13G File 005-94027

SCHEDULE 13G

Filing date
04 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .